Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth
NCT06349122Phase 3Not yet recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Oct 2026
- Primary completion
- Jun 2029
01
Overview
Phase 3, randomised, open-label trial in bacterial vaginosis (BV), Vaginal dysbiosis and preterm birth (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Rate of preterm birth. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
bacterial vaginosis (BV)Vaginal dysbiosispreterm birth
Beyond the preview
Go deeper on NCT06349122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06349122.